Department of Thoracic Surgery, Peking University First Hospital, Peking University, Beijing, China.
Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
PLoS One. 2020 Sep 17;15(9):e0239281. doi: 10.1371/journal.pone.0239281. eCollection 2020.
Lobar lymph node metastases in non-primary tumor-bearing lobes (NTBL) are rarely reported. This study examined the risk factors of lobar lymph node metastasis in NTBL.
We retrospectively studied 301 patients with non-small-cell lung cancer (NSCLC) who underwent surgical pulmonary resection with systematic lymph node dissection plus extended lobar lymph node dissection of NTBL. Patients were classified into positive and negative NTBL groups. Unconditional logistic regression was used to identify the risk factors for lobar lymph node metastasis in NTBL.
NTBL lobar lymph nodes were identified in 38 patients (12.6%). A higher proportion of adenocarcinomas occurred in the positive NTBL group compared to the negative NTBL group (73.7% vs. 46.4%, P = 0.01). Risk of NTBL lobar lymph node metastases was significantly elevated in the lower lobe of primary site compared to the upper lobe (OR = 2.61, 95% CI = 1.26-5.75, P = 0.01), and with adenocarcinomas compared to squamous cell carcinomas (OR = 2.75, 95% CI = 1.09-7.65, P = 0.04). No differences were observed when comparing left and right lobes. NTBL lobar lymph node metastasis was most often observed among patients with larger tumor size, N1/N2 nodal involvement, with lymph vascular invasion (LVI), and visceral pleural invasion (VPI).
NTBL lobar lymph node metastases occurred more often in patients with a primary NSCLC tumor in the lower lobe, with adenocarcinomas, larger tumor size, N1/N2 nodal involvement, LVI or VPI. Extended lymphadenectomy including NTBL nodes may be clinically advantageous when these risk factors are present.
非原发性肿瘤肺叶(NTBL)的肺门淋巴结转移很少见。本研究旨在探讨 NTBL 肺门淋巴结转移的危险因素。
回顾性分析了 301 例接受肺叶切除术加系统淋巴结清扫加 NTBL 扩展淋巴结清扫的非小细胞肺癌(NSCLC)患者。将患者分为 NTBL 阳性组和 NTBL 阴性组。采用非条件 logistic 回归分析 NTBL 肺门淋巴结转移的危险因素。
38 例(12.6%)患者的 NTBL 肺叶淋巴结被检出。NTBL 阳性组中腺癌的比例明显高于 NTBL 阴性组(73.7% vs. 46.4%,P = 0.01)。与上叶相比,原发部位下叶的 NTBL 肺门淋巴结转移风险显著升高(OR = 2.61,95%CI = 1.26-5.75,P = 0.01),与鳞癌相比,腺癌的风险也显著升高(OR = 2.75,95%CI = 1.09-7.65,P = 0.04)。左、右肺叶之间无差异。NTBL 肺门淋巴结转移多见于肿瘤较大、N1/N2 淋巴结受累、有淋巴血管侵犯(LVI)和内脏胸膜侵犯(VPI)的患者。
NTBL 肺门淋巴结转移更常见于原发性 NSCLC 肿瘤在下叶、腺癌、肿瘤较大、N1/N2 淋巴结受累、LVI 或 VPI 的患者。当存在这些危险因素时,扩展淋巴结清扫术包括 NTBL 淋巴结可能具有临床优势。